The paucity of data regarding the extent of hepatitis delta virus (HDV) associated health care burden in the United States is an important obstacle to assessing the cost‐effectiveness of potential… Click to show full abstract
The paucity of data regarding the extent of hepatitis delta virus (HDV) associated health care burden in the United States is an important obstacle to assessing the cost‐effectiveness of potential intervention strategies. In this study, we characterized the health care use and cost burdens of HDV in the United States using real‐world claims data.
               
Click one of the above tabs to view related content.